Stay updated on MDMA in Moderate Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the MDMA in Moderate Hepatic Impairment Clinical Trial page.

Latest updates to the MDMA in Moderate Hepatic Impairment Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record history now includes options to check who can join and to find contact information. A new page revision note shows 'Revision: v3.6.0', indicating an update to the site's version.SummaryDifference0.4%

- Check16 days agoChange DetectedThe page history now shows a new revision, v3.5.5, replacing the previous v3.5.4, indicating an administrative update to the record metadata rather than substantive trial content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe Record History now shows a new revision label (v3.5.4) replacing the previous v3.5.3, indicating an update to the page's revision metadata rather than changes to the study data or descriptions.SummaryDifference0.1%

- Check51 days agoChange DetectedResilient Pharmaceuticals is now listed as the Sponsor/Responsible Party, replacing Lykos Therapeutics, indicating a shift in the organization accountable for the study records. This change affects who coordinates communications and regulatory submissions for the trial.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays an updated UI/build revision number (v3.5.3 instead of v3.5.2), reflecting a platform/version change rather than a change to the trial record itself.SummaryDifference0.1%

- Check65 days agoChange DetectedThe history now shows a new revision v3.5.2, replacing the previous revision v3.5.0.SummaryDifference0.1%

Stay in the know with updates to MDMA in Moderate Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MDMA in Moderate Hepatic Impairment Clinical Trial page.